Cardiovascular precision medicine - A pharmacogenomic perspective.

Camb Prism Precis Med · 2023 · PMC10953758 · PMID 38550953

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP = 0.06so close (0.05 < p ≤ 0.1)

In the TAILOR-PCI trial (Pereira et al., 2020 ), patients with either stable coronary disease or ACS undergoing PCI showed lower rates of the composite cardiovascular primary endpoint in the genotype-guided group compared to the non-genotype-guided cohort at 1-year follow-up, but this did not reach statistical significance (HR 0.66; 95% CI 0.43–1.02; P = 0.06) (Pereira et al., 2020 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.